Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial (Q45219658)
Jump to navigation
Jump to search
scientific article published on 5 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial |
scientific article published on 5 November 2014 |
Statements
1 reference
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial (English)
1 reference
1 reference
Pasi A Jänne
1 reference
Sai-Hong I Ou
1 reference
Dong-Wan Kim
1 reference
Geoffrey R Oxnard
1 reference
Renato Martins
1 reference
Frank Dunphy
1 reference
Makoto Nishio
1 reference
Joseph O'Connell
1 reference
Cloud Paweletz
1 reference
Ian Taylor
1 reference
Hui Zhang
1 reference
Zelanna Goldberg
1 reference
Tony Mok
1 reference
5 November 2014
1 reference
1 reference
15
1 reference
13
1 reference
1433-1441
1 reference
Identifiers
1 reference
1 reference